Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Feb;27(2):700–703. doi: 10.1128/iai.27.2.700-703.1980

Chemotaxigenesis by encapsulated Staphylococcus aureus M.

D J Schmeling, P K Peterson, I M Barr, Y Kim, P G Quie
PMCID: PMC550823  PMID: 7380548

Abstract

Although encapsulated Staphylococcus aureus M is not opsonized by normal human serum, as a chemotaxigen this organism behaved similarly to an unencapsulated variant strain. For optimal chemotaxigenesis, an intact classical complement pathway was required, and C5a appeared to be the major chemotaxin.

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craddock P. R., Hammerschmidt D., White J. G., Dalmosso A. P., Jacob H. S. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977 Jul;60(1):260–264. doi: 10.1172/JCI108763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fine D. P. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun. 1977 Apr;16(1):124–128. doi: 10.1128/iai.16.1.124-128.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Forsgren A., Mclean R. H., Michael A. F., Quie P. G. Studies of the alternate pathway in chelated serum. J Lab Clin Med. 1975 Jun;85(6):904–912. [PubMed] [Google Scholar]
  4. Gallin J. I., Clark R. A., Frank M. M. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol. 1975 Jan;3(3):334–346. doi: 10.1016/0090-1229(75)90020-3. [DOI] [PubMed] [Google Scholar]
  5. Grov A., Sveen K. Induction of leukochemotaxis by peptidoglycan of Staphylococcus aureus. Acta Pathol Microbiol Scand B. 1978 Dec;86B(6):375–378. doi: 10.1111/j.1699-0463.1978.tb00059.x. [DOI] [PubMed] [Google Scholar]
  6. KOENIG M. G. Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants. Yale J Biol Med. 1962 Jun;34:537–559. [PMC free article] [PubMed] [Google Scholar]
  7. Kim Y., Friend P. S., Dresner I. G., Yunis E. J., Michael A. F. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis. Am J Med. 1977 May;62(5):765–771. doi: 10.1016/0002-9343(77)90881-6. [DOI] [PubMed] [Google Scholar]
  8. Melly M. A., Duke L. J., Liau D. F., Hash J. H. Biological properties of the encapsulated Staphylococcus aureus M. Infect Immun. 1974 Aug;10(2):389–397. doi: 10.1128/iai.10.2.389-397.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Miller M. E. Pathology of chemotaxis and random mobility. Semin Hematol. 1975 Jan;12(1):59–82. [PubMed] [Google Scholar]
  10. O'Flaherty J. T., Kreutzer D. L., Ward P. A. Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol. 1978 Mar;90(3):537–550. [PMC free article] [PubMed] [Google Scholar]
  11. Peterson P. K., Kim Y., Wilkinson B. J., Schmeling D., Michael A. F., Quie P. G. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun. 1978 Jun;20(3):770–775. doi: 10.1128/iai.20.3.770-775.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peterson P. K., Wilkinson B. J., Kim Y., Schmeling D., Quie P. G. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun. 1978 Mar;19(3):943–949. doi: 10.1128/iai.19.3.943-949.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Russell R. J., Wilkinson P. C., McInroy R. J., McKay S., McCartney A. C., Arbuthnott J. P. Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes. J Med Microbiol. 1976 Nov;9(4):433–439. doi: 10.1099/00222615-9-4-433. [DOI] [PubMed] [Google Scholar]
  14. Schmeling D. J., Peterson P. K., Hammerschmidt D. E., Kim Y., Verhoef J., Wilkinson B. J., Quie P. G. Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun. 1979 Oct;26(1):57–63. doi: 10.1128/iai.26.1.57-63.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Snyderman R., Phillips J., Mergenhagen S. E. Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun. 1970 Jun;1(6):521–525. doi: 10.1128/iai.1.6.521-525.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Snyderman R., Shin H. S., Phillips J. K., Gewurz H., Mergenhagen S. E. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol. 1969 Sep;103(3):413–422. [PubMed] [Google Scholar]
  17. Stossel T. P., Field R. J., Gitlin J. D., Alper C. A., Rosen F. S. The opsonic fragment of the third component of human complement (C3). J Exp Med. 1975 Jun 1;141(6):1329–1347. doi: 10.1084/jem.141.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WOOD W. B., Jr Phagocytosis, with particular reference to encapsulated bacteria. Bacteriol Rev. 1960 Mar;24(1):41–49. doi: 10.1128/br.24.1.41-49.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES